Surgical Treatment of Bone Sarcoma.
Felix Marius BläsiusHeide DelbrückFrank HildebrandUlf Krister HofmannPublished in: Cancers (2022)
Bone sarcomas are rare primary malignant mesenchymal bone tumors. The three main entities are osteosarcoma, chondrosarcoma, and Ewing sarcoma. While prognosis has improved for affected patients over the past decades, bone sarcomas are still critical conditions that require an interdisciplinary diagnostic and therapeutic approach. While radiotherapy plays a role especially in Ewing sarcoma and chemotherapy in Ewing sarcoma and osteosarcoma, surgery remains the main pillar of treatment in all three entities. After complete tumor resection, the created bone defects need to be reconstructed. Possible strategies are implantation of allografts or autografts including vascularized bone grafts (e.g., of the fibula). Around the knee joint, rotationplasty can be performed or, as an alternative, the implantation of (expandable) megaprostheses can be performed. Challenges still associated with the implantation of foreign materials are aseptic loosening and infection. Future improvements may come with advances in 3D printing of individualized resection blades/implants, thus also securing safe tumor resection margins while at the same time shortening the required surgical time. Faster osseointegration and lower infection rates may possibly be achieved through more elaborate implant surface structures.
Keyphrases
- bone mineral density
- soft tissue
- bone loss
- bone regeneration
- end stage renal disease
- early stage
- chronic kidney disease
- radiation therapy
- stem cells
- body composition
- mass spectrometry
- bone marrow
- high resolution
- atrial fibrillation
- acute coronary syndrome
- peritoneal dialysis
- patient reported outcomes
- percutaneous coronary intervention
- coronary artery bypass